Get the Stockscreener App
41.06
4.02%
-1.72
Pre-market:
42.04
0.98
+2.39%
Veracyte Inc stock is traded at $41.06, with a volume of 716.55K.
It is down -4.02% in the last 24 hours and down -5.00% over the past month.
See More
Previous Close:
$42.78
Open:
$43.09
24h Volume:
716.55K
Relative Volume:
0.99
Market Cap:
$3.29B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-54.75
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
-3.37%
1M Performance:
-5.00%
6M Performance:
+80.48%
1Y Performance:
+54.83%
1-Day Range:
$40.25
$43.52
1-Week Range:
$40.25
$43.95
52-Week Range:
$18.61
$46.00
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
41.06 | 3.29B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
556.99 | 213.05B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
237.62 | 171.63B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
143.43 | 40.54B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.96 | 35.93B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
418.63 | 34.28B | 3.84B | 866.24M | 792.60M | 10.37 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Veracyte Inc (VCYT) Shares Gap Down to $40.865 on Jan 14 - GuruFocus.com
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Catherine Wood's Strategic Reduction in Veracyte Inc Shares - GuruFocus.com
Diversified Trust Co Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To Profitability - Yahoo Finance
Veracyte Gains 44% in a Year: What's Driving the Stock? - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Veracyte director Karin Eastham sells shares worth $403,005 By Investing.com - Investing.com Australia
Insider Selling: Veracyte, Inc. (NASDAQ:VCYT) Director Sells 10,000 Shares of Stock - MarketBeat
Veracyte director Karin Eastham sells shares worth $403,005 - Investing.com
Veracyte Inc (VCYT) Stock Price Up 3.58% on Jan 6 - GuruFocus.com
Principal Financial Group Inc. Lowers Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now - MSN
Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) Target Price at $41.13 - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Sees Significant Decrease in Short Interest - MarketBeat
Stifel Financial Corp Sells 19,420 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte (NASDAQ:VCYT) Shares Gap DownShould You Sell? - MarketBeat
Geode Capital Management LLC Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Barclays PLC Buys 85,033 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
HighTower Advisors LLC Takes $554,000 Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Zacks Investment Research
Veracyte CEO Marc Stapley sells shares worth $242,736 By Investing.com - Investing.com Canada
Veracyte CEO Marc Stapley sells shares worth $242,736 - Investing.com India
Lord Abbett & CO. LLC Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte - Yahoo Finance
3 Medical Instruments Industry Stocks To Buy On The GenAI Wave - Barchart
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Fmr LLC - MarketBeat
US Exchange: 3 Stocks That May Be Trading Below Fair Value - Simply Wall St
Jane Street Group LLC Raises Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - MSN
Veracyte (VCYT) Just Flashed Golden Cross Signal: Do You Buy? - MSN
Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer Diagnostics - Yahoo! Voices
Veracyte (VCYT) Shares Rebounded in Q3 - Insider Monkey
Neo Ivy Capital Management Buys Shares of 24,116 Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen - Yahoo Finance
Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% - Yahoo Finance
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Veracyte: Getting Frothy (NASDAQ:VCYT) - Seeking Alpha
Zacks Investment Management Makes New $1.12 Million Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Wellington Management Group LLP Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Cerity Partners LLC Purchases New Shares in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
48,193 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by XTX Topco Ltd - MarketBeat
Verition Fund Management LLC Takes $1.32 Million Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Veracyte Inc Stock (VCYT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EASTHAM KARIN | Director |
Jan 02 '25 |
Option Exercise |
5.28 |
10,000 |
52,800 |
28,497 |
| EASTHAM KARIN | Director |
Jan 02 '25 |
Sale |
40.30 |
10,000 |
403,006 |
18,497 |
0.17%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):